Breaking News Instant updates and real-time market news.

NPTN

NeoPhotonics

$6.10

0.59 (10.71%)

, ACIA

Acacia Communications

$45.06

2.35 (5.50%)

08:32
08/24/17
08/24
08:32
08/24/17
08:32

China Mobile tender offer looks 'significant' for optical stocks, says Needham

Needham analyst Alex Henderson said the coherent transport ports tender offer announced by China Mobile (CHL) on its Chinese language website looks "significant in scale and material" for optical stocks. He noted that NeoPhotonics (NPTN) gets roughly 60% of revenue from China and is directly exposed to coherent demand, while Acacia (ACIA) gets 50% of revenue from China and is also directly exposed. He noted that Oclaro (OCLR), Lumentum (LITE), Finisar (FNSR) all have China exposure, but are less tied to coherent, while adding that "this order has no bearing" on Applied Optoelectronics (AAOI).

NPTN

NeoPhotonics

$6.10

0.59 (10.71%)

ACIA

Acacia Communications

$45.06

2.35 (5.50%)

OCLR

Oclaro

$8.74

0.46 (5.56%)

LITE

Lumentum

$56.00

1.65 (3.04%)

FNSR

Finisar

$24.68

0.78 (3.26%)

FN

Fabrinet

$38.59

1.65 (4.47%)

AAOI

Applied Optoelectronics

$63.51

2.49 (4.08%)

  • 29

    Aug

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

NPTN NeoPhotonics
$6.10

0.59 (10.71%)

06/29/17
DADA
06/29/17
INITIATION
Target $9
DADA
Neutral
NeoPhotonics initiated with a Neutral at DA Davidson
DA Davidson analyst Mark Kelleher started NeoPhotonics with a Neutral rating and $9 price target.
07/24/17
RAJA
07/24/17
DOWNGRADE
Target $9
RAJA
Outperform
NeoPhotonics downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Simon Leopold downgraded NeoPhotonics to Outperform and maintained its $9 price target to reflect a more cautious stance on the timing of a recovery in China, combined with recent share appreciation.
05/25/17
RSBL
05/25/17
INITIATION
Target $13
RSBL
Buy
NeoPhotonics initiated with a Buy at Rosenblatt
Rosenblatt analyst Jun Zhang initiated NeoPhotonics with a Buy and a $13 price target due to potential benefits from China Mobile's upcoming Phase 12, improving EML yield rate and gross margin, a new design win of CFP2-LR at Huawei, sustainable growth of Coherent products at Hisilicon, expanding business at InnoLight, and real estate assets in Shenzhen and Tokyo with an estimated value of $400M.
05/22/17
RSBL
05/22/17
NO CHANGE
RSBL
China Telecom has begun work on Metro upgrade plan, says Rosenblatt
Rosenblatt Securities said China Telecom (CHA) has begun work on its Metro upgrade plan and the firm believes it will release tenders for both provincial and Metro in the timeframe of September to October. Companies in the optical equipment space that could benefit from China's upgrade cycle include Oclaro (OCRL), Finisar (FNSR), Lumentum (LITE), NeoPhotonics (NPTN), Acacia Communications (ACIA) and Viavi (VIAV).
ACIA Acacia Communications
$45.06

2.35 (5.50%)

06/22/17
DADA
06/22/17
INITIATION
Target $61
DADA
Buy
Acacia Communications initiated with a Buy at DA Davidson
DA Davidson analyst Mark Kelleher initiated Acacia Communications with a Buy and a $61 price target telling investors its new CFP-ACO product positions the company for 2018 growth.
07/17/17
NEED
07/17/17
NO CHANGE
Target $50
NEED
Buy
Acacia Communications price target lowered to $50 from $65 at Needham
Needham analyst Alex Henderson lowered his price target for Acacia Communications to $50 from $65 to reflect the combined impact of the Q2 miss and estimate cuts, as well as the hit to investor confidence in the stock and likely in management. The analyst reiterates a Buy rating on the shares.
05/11/17
MSCO
05/11/17
DOWNGRADE
MSCO
Equal Weight
Acacia Communications downgraded to Equal Weight at Morgan Stanley
Morgan Stanley analyst Meta Marshall downgraded Acacia Communications to Equal Weight form Overweight with a $45 price target following the company's reduced guidance and volatility around China/DCI demand.
OCLR Oclaro
$8.74

0.46 (5.56%)

08/03/17
STFL
08/03/17
NO CHANGE
STFL
Oclaro reported impressive Q4 results, says Stifel
Stifel analyst Patrick Newton says that Oclaro reported impressive Q4 results, with profitability that "stands out." The analyst adds that the company's CFP2-ACO and QSFP28 products have "positive momentum." He keeps a Buy rating on the shares.
07/12/17
COWN
07/12/17
NO CHANGE
Target $60
COWN
Outperform
Oclaro investors will eventually be rewarded, says Cowen
Cowen analyst Ken Cacciatore said the CRL Ocular received related to Dextenza's manufacturing process is disappointing, but is hopeful the issue will be resolved within the next year. At current levels, Cacciatore believes patient investors will eventually be rewarded for the OTX-TP glaucoma opportunity and reiterates his Outperform rating and $60 price target on shares.
08/03/17
JEFF
08/03/17
NO CHANGE
Target $12.5
JEFF
Buy
Oclaro results a relief after MACOM commentary, says Jefferies
Jefferies analyst James Kisner views Oclaro's (OCLR) Q4 results as "solid" and continues to believe the company will surprise investors to the upside. The quarter is likely a relief after negative China commentary yesterday from MACOM (MTSI), Kisner tells investors in a research note. He raised his price target for the shares to $12.50 from $12 and keeps a Buy rating on the name.
06/23/17
06/23/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Starbucks (SBUX) initiated with an Overweight at KeyBanc. 2. Wix.com (WIX) initiated with an Outperform at Wedbush. 3. Red Hat (RHT) initiated with a Neutral at Piper Jaffray. 4. Amgen (AMGN) initiated with a Hold at Deutsche Bank. 5. Oclaro (OCLR) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
LITE Lumentum
$56.00

1.65 (3.04%)

08/09/17
08/09/17
NO CHANGE
Target $70

Buy
Lumentum target raised to $70 on better than expected Apple order at Rosenblatt
As previously reported, Rosenblatt analyst Jun Zhang raised the firm's price target on Lumentum to $70 from $66 after the company confirmed its receipt of a $200M 3D sensing order for calendar 2017, believed to be from Apple (AAPL). This order was better than the firm's expectations and the consensus view, said Zhang, who keeps a Buy rating on Lumentum shares.
08/09/17
CHLM
08/09/17
NO CHANGE
Target $75
CHLM
Buy
Lumentum price target raised to $75 from $60 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Lumentum to $75 and reiterates a Buy rating on the shares following today's Q4 results.
08/10/17
PIPR
08/10/17
NO CHANGE
Target $68
PIPR
Overweight
Lumentum price target raised to $68 from $58 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Lumentum (LITE) to $68 saying a surge in orders for 3D Sensing VCSELs offset weaker than expected core optics in the June quarter. Jensen believes, based on conversations with industry contacts, that Lumentum captured 75%-100% of initial shipments of both the high and low-power VCSEL into Apple's (AAPL) iPhone 8. The 3D sensing market is a "significant earnings enhancement opportunity" for Lumentum, Jensen writes in a post-earnings research note. He reiterates an Overweight rating on the shares.
08/24/17
RILY
08/24/17
NO CHANGE
RILY
Buy
China Mobile tender 'could be needle-mover,' but mix unclear, says B. Riley
B. Riley analyst Dave Kang noted that China Mobile (CHL) has issued a procurement notice for approximately 42,000 ports, but said there was no information on the mix of 10G/100G, which would be the most relevant information to determine its significance. Various industry executives he spoke with said it would be difficult to assess the impact of the tender without knowing the mix of 10G/100G and share allocations between customers. If this tender is mostly for 100G, it "could be a needle-mover for the optical component industry," added Kang, who has a Buy rating on Lumentum (LITE) shares.
FNSR Finisar
$24.68

0.78 (3.26%)

06/16/17
CHLM
06/16/17
NO CHANGE
Target $38
CHLM
Buy
Finisar upside drivers all coming in second half, says Craig-Hallum
Craig-Hallum analyst Richard Shannon said that despite Finisar's below consensus guidance for next quarter, the company's commentary with its Q4 report offered reasons for optimism in the second half of 2017 from a number of areas, including 3D sensing, 100G Datacom, ROADM line cards and Analog Coherent Optics. He sees a favorable risk/reward in the shares at current levels given expectations for accelerating sales growth and improving margins and keeps a Buy rating and $38 target on Finisar.
06/29/17
DADA
06/29/17
INITIATION
Target $40
DADA
Buy
Finisar initiated with a Buy at DA Davidson
DA Davidson analyst Mark Kelleher started Finisar with a Buy rating and $40 price target.
06/16/17
JEFF
06/16/17
NO CHANGE
Target $34
JEFF
Buy
Finisar's business to improve from here, says Jefferies
Jefferies analyst James Kisner says Finisar's (FNSR) weaker than expected Q1 outlook was widely expected and that the company's expectations to ship tens of millions of units for 3D sensing in the October quarter is important. In a post-earnings research note titled "Who Cares About Q1 Guidance...Here Comes 3D Sensing! Reiterate Buy," Kisner argues Finisar's business will improve from here. He believes the talk around 3D sensing is also positive for Lumentum (LITE). The analyst keeps a Buy rating on Finisar with a $34 price target.
06/16/17
STFL
06/16/17
NO CHANGE
STFL
Finisar fundamentals likely to bottom next month, says Stifel
After Finisar reported lower than expected Q4 revenue and provided weaker than expected Q1 guidance, Stifel analyst Patrick Newton blamed several factors for the weakness, including the company's China business and 10G softness. However, the analyst says that the stock reflects the China weakness while the company's fundamentals will probably bottom next month. He keeps a $33 price target and a Buy rating on the shares.
FN Fabrinet
$38.59

1.65 (4.47%)

08/23/17
JPMS
08/23/17
NO CHANGE
Target $54
JPMS
Overweight
Fabrinet weak Q1 guidance 'largely anticipated,' says JPMorgan
JPMorgan analyst Paul Coster said a temporary slowdown in Chinese telco demand is making for a slow start to FY18 for Fabrinet, leading to the company's "weak" Q1 guidance, though he contends that was "largely anticipated" in the market. The analyst, who sees the stock to "trade sideways" until more positive demand data points are apparent from Fabrintet customers, trimmed his price target on the stock to $54 from $57 but keeps an Overweight rating on the shares.
08/22/17
NEED
08/22/17
NO CHANGE
NEED
Fabrinet outlook remains positive, says Needham
Needham analyst Alex Henderson says that Fabrinet reported "solid" results but provided "soft" guidance. The analyst blames the soft guidance on product transitions at two of its customers, "a lull in ROADM demand, and a product transition in industrial laser." He expects all of these headwinds to be temporary and keeps a $60 price target and a Strong Buy rating on the stock.
08/22/17
PIPR
08/22/17
NO CHANGE
Target $51
PIPR
Overweight
Fabrinet guide down anticipated, creates buying opportunity, says Piper Jaffray
Piper Jaffray analyst Troy Jensen said Fabrinet's below consensus guidance for the September quarter was highly anticipated given weakness previously reported by its customers and would argue that the company's forecast being down roughly 3% sequentially is significantly better than most in the optical space. The analyst, who expects 2018 to be the year Fabrinet experiences outsized growth in datacom sales, keeps an Overweight rating on the shares and would be a buyer on post-earnings weakness. Jensen lowered his price target on Fabrinet shares to $51 from $55.
07/20/17
BWSF
07/20/17
NO CHANGE
Target $25
BWSF
Sell
Applied Optoelectronics to lose some Amazon orders in Q4, says BWS Financial
BWS Financial analyst Hamed Khorsand believes Applied Optoelectronics (AAOI) provided warning in its latest press release that its 40G business will erode in the latter part of the year. Language in the press release comes after Fabrinet (FN) stated that it is ramping a line of 100G for Amazon.com (AMZN), a 56% Applied Optoelectronics customer in Q1, Khorsand tells investors in a research note. The analyst says he learned from industry sources that shipments would begin in Q4, implying Applied Optoelectronics would begin losing some orders from Amazon. Khorsand remains confident being short the stock despite last week's positive preannouncement. He keeps a Sell rating on the shares with a $25 price target. Applied Optoelectronics in afternoon trading is up 79c to $93.33.
AAOI Applied Optoelectronics
$63.51

2.49 (4.08%)

08/07/17
CHLM
08/07/17
NO CHANGE
Target $95
CHLM
Buy
Applied Optoelectronics selloff creates buying opportunity, says Craig-Hallum
Craig-Hallum analyst Richard Shannon notes that Applied Optoelectronics provided disappointing Q3 guidance that was impacted by lower 40G sales. With a strong cost structure, willingness to provide capacity and strong track record, the analyst believes Applied Optoelectronics can gather strong share if it executes, which it has done very well in the past year. He reiterates a Buy rating and a $95 price target on the shares.
08/16/17
BWSF
08/16/17
NO CHANGE
BWSF
Applied Optoelectronics facing price erosion, says BWS Financial
BWS Financial analyst Hamed Khorsand said Applied Optoelectronics (AAOI) held an investor call to describe the manufacturing efficiencies the company has and the advantage it serves, but the little bit of commentary from management during the Q&A session may scare bulls further. The company is facing price erosion at an accelerated rate that could cause quarterly numbers to continue to trend down, the analyst wrote. Khorsand said commentary regarding gross margins and pricing further give credence to his Sell rating and $25 price target.
08/16/17
RAJA
08/16/17
NO CHANGE
RAJA
Strong Buy
Raymond James maintains Strong Buy rating on Applied Optoelectronics
Raymond James analyst Applied Simon Leopold maintained a Strong Buy and $107 price target on Applied Optoelectronics following a recent field trip. The analyst said Applied often gets grouped in with optical component stocks, but its differentiated through its focus on data center applications, scale and automation. Simon recommends investors take the time to listen to the story and further understanding will lead to increased appreciation.
08/07/17
RAJA
08/07/17
NO CHANGE
Target $107
RAJA
Strong Buy
Applied Optoelectronics weakness a buying opportunity, says Raymond James
Raymond James analyst Simon Leopold said the selloff in Applied Optoelectronics is overdone and said the sales decline due to lower 40G sales will be overtaken by 100G growth. He sees 2018 sales growth of approximately 20% and would views Friday's selloff as a buying opportunity for risk tolerant investors. Leopold rates Applied Optoelectronics a Strong Buy with a $107 price target.

TODAY'S FREE FLY STORIES

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

, ABBV

AbbVie

$118.60

3.7 (3.22%)

04:55
02/18/18
02/18
04:55
02/18/18
04:55
Conference/Events
American Academy of Dermatology holds annual meeting »

2018 AAD Annual Meeting…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

AGN

Allergan

$164.04

-0.43 (-0.26%)

ALIOF

Actelion

ARDX

Ardelyx

$5.80

-0.2 (-3.33%)

BVX

Bovie Medical

$2.50

0.1 (4.17%)

CELG

Celgene

$95.26

-0.88 (-0.92%)

CUTR

Cutera

$48.40

-2.1 (-4.16%)

HSIC

Henry Schein

$69.52

1.14 (1.67%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

LLY

Eli Lilly

$78.97

0.95 (1.22%)

LMNS

Lumenis

MYGN

Myriad Genetics

$32.81

-0.57 (-1.71%)

MYL

Mylan

$42.14

0.49 (1.18%)

NVS

Novartis

$86.91

0.23 (0.27%)

PFE

Pfizer

$36.26

0.55 (1.54%)

PG

Procter & Gamble

$82.60

0.19 (0.23%)

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

REGN

Regeneron

$332.15

-1.03 (-0.31%)

SNY

Sanofi

$39.91

0.19 (0.48%)

UL

Unilever; also tag UN

$53.55

-0.22 (-0.41%)

UN

Unilever; also tag UL

$54.59

-0.15 (-0.27%)

WTKWY

Wolters Kluwer

$49.37

-0.27 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 12

    Mar

  • 12

    Mar

  • 25

    Mar

  • 29

    Mar

  • 04

    Apr

  • 23

    Apr

  • 23

    Apr

  • 02

    May

  • 03

    May

  • 17

    May

  • 30

    May

  • 13

    Nov

MRVL

Marvell

$22.68

-0.06 (-0.26%)

, CAVM

Cavium

$87.16

-0.09 (-0.10%)

14:55
02/17/18
02/17
14:55
02/17/18
14:55
Conference/Events
Cavium to host special shareholder meeting »

Special Shareholder…

MRVL

Marvell

$22.68

-0.06 (-0.26%)

CAVM

Cavium

$87.16

-0.09 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 08

    Mar

CAVM

Cavium

$87.16

-0.09 (-0.10%)

, MRVL

Marvell

$22.68

-0.06 (-0.26%)

14:51
02/17/18
02/17
14:51
02/17/18
14:51
Conference/Events
Marvell to host special shareholder meeting »

Special Shareholder…

CAVM

Cavium

$87.16

-0.09 (-0.10%)

MRVL

Marvell

$22.68

-0.06 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

DEL

Deltic Timber

$98.45

1.77 (1.83%)

, PCH

Potlatch

$54.75

0.75 (1.39%)

14:45
02/17/18
02/17
14:45
02/17/18
14:45
Conference/Events
Potlatch to host special shareholder meeting »

Special Shareholder…

DEL

Deltic Timber

$98.45

1.77 (1.83%)

PCH

Potlatch

$54.75

0.75 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

PCH

Potlatch

$54.75

0.75 (1.39%)

, DEL

Deltic Timber

$98.45

1.77 (1.83%)

14:42
02/17/18
02/17
14:42
02/17/18
14:42
Conference/Events
Deltic Timber to host special shareholder meeting »

Special shareholder…

PCH

Potlatch

$54.75

0.75 (1.39%)

DEL

Deltic Timber

$98.45

1.77 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$20.42

0.67 (3.39%)

09:31
02/17/18
02/17
09:31
02/17/18
09:31
Periodicals
Snap CEO sold $50M in stock this week, Recode reports »

Snap CEO Evan Spiegel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 07

    Mar

GLPG

Galapagos NV

$115.33

-1.4 (-1.20%)

, MPSYY

MorphoSys

$46.29

1.29 (2.87%)

09:27
02/17/18
02/17
09:27
02/17/18
09:27
Hot Stocks
Galapagos NV, MorphoSys present results from Phase 1 study with MOR106 in AD »

Galapagos NV (GLPG) and…

GLPG

Galapagos NV

$115.33

-1.4 (-1.20%)

MPSYY

MorphoSys

$46.29

1.29 (2.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$360.53

-0.47 (-0.13%)

09:22
02/17/18
02/17
09:22
02/17/18
09:22
Hot Stocks
Lockheed Martin receives Freedom-variant FFG conceptual design contract »

The U.S. Navy awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

  • 30

    May

UAA

Under Armour; also tag UA

$17.36

-1.05 (-5.70%)

, UA

Under Armour; also tag UAA

$15.78

-0.76 (-4.59%)

09:11
02/17/18
02/17
09:11
02/17/18
09:11
Periodicals
Bears, bulls battle over Under Armour, Barron's says »

In a follow-up story,…

UAA

Under Armour; also tag UA

$17.36

-1.05 (-5.70%)

UA

Under Armour; also tag UAA

$15.78

-0.76 (-4.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOV

Hovnanian

$2.24

0.12 (5.66%)

09:04
02/17/18
02/17
09:04
02/17/18
09:04
Periodicals
Hovnanian stock too cheap to ignore, Barron's says »

Hovnanian Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

, JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

09:00
02/17/18
02/17
09:00
02/17/18
09:00
Periodicals
JPMorgan, Walmart cash flow yields exceed dividend yields, Barron's says »

The cash flow yields of…

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

WMT

Walmart

$104.78

1.55 (1.50%)

PFE

Pfizer

$36.26

0.55 (1.54%)

CSCO

Cisco

$44.33

0.25 (0.57%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

PEP

PepsiCo

$111.06

0.09 (0.08%)

MMM

3M

$236.67

1.8 (0.77%)

BMY

Bristol-Myers

$68.96

-0.02 (-0.03%)

UTX

United Technologies

$129.26

-0.74 (-0.57%)

TXN

Texas Instruments

$104.47

-0.1 (-0.10%)

ABT

Abbott

$60.17

0.67 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 13

    Mar

  • 29

    Mar

  • 04

    Apr

  • 13

    Apr

  • 30

    May

  • 14

    Jul

  • 12

    Oct

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

, GOOG

Alphabet

$1,094.80

5.28 (0.48%)

08:56
02/17/18
02/17
08:56
02/17/18
08:56
Periodicals
Alphabet, Citi well positioned for later stages of market rally, Barron's says »

It is time for investors…

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

GOOG

Alphabet

$1,094.80

5.28 (0.48%)

C

Citi

$76.82

-0.26 (-0.34%)

CMI

Cummins

$165.60

0.58 (0.35%)

LRCX

Lam Research

$187.91

2.2 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 18

    Mar

  • 28

    Mar

  • 29

    Mar

  • 30

    May

GE

General Electric

$15.05

0.2 (1.35%)

08:48
02/17/18
02/17
08:48
02/17/18
08:48
Periodicals
General Electric stock could drop another 10%, Barron's says »

General Electric lost $6B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$63.19

-0.52 (-0.82%)

, VMC

Vulcan Materials

$126.57

-6.9 (-5.17%)

08:32
02/17/18
02/17
08:32
02/17/18
08:32
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

JEC

Jacobs Engineering

$63.19

-0.52 (-0.82%)

VMC

Vulcan Materials

$126.57

-6.9 (-5.17%)

PWR

Quanta Services

$35.07

0.24 (0.69%)

EXP

Eagle Materials

$102.75

-3.83 (-3.59%)

FLR

Fluor

$57.63

-0.22 (-0.38%)

USCR

U.S. Concrete

$78.00

-1.4 (-1.76%)

ACM

Aecom

$35.36

0.08 (0.23%)

CBI

CB&I

$18.71

0.04 (0.21%)

GVA

Granite Construction

$60.36

2.69 (4.66%)

CAT

Caterpillar

$156.29

-3.69 (-2.31%)

MLM

Martin Marietta

$216.25

-6.34 (-2.85%)

V

Visa

$121.85

-0.43 (-0.35%)

AA

Alcoa

$47.36

-0.21 (-0.44%)

ARNC

Arconic

$25.36

0.14 (0.56%)

CENX

Century Aluminum

$24.12

1.85 (8.31%)

X

U.S. Steel

$44.75

5.76 (14.77%)

STLD

Steel Dynamics

$49.40

2.26 (4.79%)

AKS

AK Steel

$5.96

0.72 (13.74%)

CLF

Cleveland-Cliffs

$7.92

0.55 (7.46%)

NUE

Nucor

$68.54

2.96 (4.51%)

MT

ArcelorMittal

$36.48

1.19 (3.37%)

TKR

Timken

$45.00

-0.08 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 01

    Mar

  • 14

    Mar

  • 23

    May

  • 30

    May

04:55
02/17/18
02/17
04:55
02/17/18
04:55
Conference/Events
Cambridge Healthtech Institute to hold a conference »

Molecular Med Tri-Con…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

, ABBV

AbbVie

$118.60

3.7 (3.22%)

04:55
02/17/18
02/17
04:55
02/17/18
04:55
Conference/Events
American Academy of Dermatology holds annual meeting »

2018 AAD Annual Meeting…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

AGN

Allergan

$164.04

-0.43 (-0.26%)

ALIOF

Actelion

ARDX

Ardelyx

$5.80

-0.2 (-3.33%)

BVX

Bovie Medical

$2.50

0.1 (4.17%)

CELG

Celgene

$95.26

-0.88 (-0.92%)

CUTR

Cutera

$48.40

-2.1 (-4.16%)

HSIC

Henry Schein

$69.52

1.14 (1.67%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

LLY

Eli Lilly

$78.97

0.95 (1.22%)

LMNS

Lumenis

MYGN

Myriad Genetics

$32.81

-0.57 (-1.71%)

MYL

Mylan

$42.14

0.49 (1.18%)

NVS

Novartis

$86.91

0.23 (0.27%)

PFE

Pfizer

$36.26

0.55 (1.54%)

PG

Procter & Gamble

$82.60

0.19 (0.23%)

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

REGN

Regeneron

$332.15

-1.03 (-0.31%)

SNY

Sanofi

$39.91

0.19 (0.48%)

UL

Unilever; also tag UN

$53.55

-0.22 (-0.41%)

UN

Unilever; also tag UL

$54.59

-0.15 (-0.27%)

WTKWY

Wolters Kluwer

$49.37

-0.27 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 12

    Mar

  • 12

    Mar

  • 25

    Mar

  • 29

    Mar

  • 04

    Apr

  • 23

    Apr

  • 02

    May

  • 03

    May

  • 17

    May

  • 30

    May

  • 13

    Nov

MIDD

Middleby

$135.00

1.94 (1.46%)

18:01
02/16/18
02/16
18:01
02/16/18
18:01
Hot Stocks
Middleby acquires Hinds-Bock Corporation, terms not disclosed »

Middleby announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.14

0.14 (0.38%)

, TWX

Time Warner

$95.37

0.38 (0.40%)

17:37
02/16/18
02/16
17:37
02/16/18
17:37
Periodicals
Breaking Periodicals news story on AT&T, Time Warner »

Judge says to rule on …

T

AT&T

$37.14

0.14 (0.38%)

TWX

Time Warner

$95.37

0.38 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

CARS

Cars.com

$29.27

0.33 (1.14%)

17:31
02/16/18
02/16
17:31
02/16/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Cars.com »

Starboard raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONTX

Onconova

$1.07

0.01 (0.94%)

17:29
02/16/18
02/16
17:29
02/16/18
17:29
Hot Stocks
683 Capital reports 21.8% stake in Onconova, says shares undervalued »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$224.19

-1.21 (-0.54%)

17:26
02/16/18
02/16
17:26
02/16/18
17:26
Hot Stocks
General Dynamics awarded $148.9M government contract modification »

General Dynamics Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$2.39

0.04 (1.70%)

17:25
02/16/18
02/16
17:25
02/16/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Antares Pharma »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

17:25
02/16/18
02/16
17:25
02/16/18
17:25
Hot Stocks
Huntington Ingalls awarded $1.43B government contract modification »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIT

AMCON Distributing

$87.50

0.13 (0.15%)

17:24
02/16/18
02/16
17:24
02/16/18
17:24
Hot Stocks
Breaking Hot Stocks news story on AMCON Distributing »

Hale Partnership reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$41.09

-0.76 (-1.82%)

, TSLA

Tesla

$335.49

1.425 (0.43%)

17:11
02/16/18
02/16
17:11
02/16/18
17:11
Periodicals
Chevy Bolt sales bolstered by Tesla delays, tax credit worries, Reuters says »

Certain potential buyers…

GM

General Motors

$41.09

-0.76 (-1.82%)

TSLA

Tesla

$335.49

1.425 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.